Union Bancaire Privee Asset Management’s West Pharmaceutical WST Stock Holding History

Union Bancaire Privee Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$2.86M	Sell	10,136 -3,488	-26%	-$998K	1.51%	28
2020 Q4	$3.86M	Sell	13,624 -3,120	-19%	-$876K	1.78%	22
2020 Q3	$4.6M	Hold	16,744	–	–	1.76%	23
2020 Q2	$3.8M	Buy	16,744 +1,542	+10%	+$303K	1.5%	30
2020 Q1	$2.31M	Sell	15,202 -3,403	-18%	-$524K	1.44%	30
2019 Q4	$2.8M	Buy	18,605 +3,000	+19%	+$437K	1.42%	32
2019 Q3	$2.21M	Sell	15,605 -800	-5%	-$110K	1.43%	32
2019 Q2	$2.05M	Buy	16,405 +4,311	+36%	+$509K	1.2%	40
2019 Q1	$1.33M	Hold	12,094	–	–	1.38%	35
2018 Q4	$1.19M	Buy	+12,094	New	+$1.31M	1.35%	37

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Union Bancaire Privee Asset Management's WST Position: Q1 2021 in Review

Union Bancaire Privee Asset Management reduced its West Pharmaceutical (WST) stake by 26% in Q1 2021, selling an estimated $998K and leaving 10,136 shares worth $2.86M. The position accounts for 1.51% of the portfolio, ranked #28.

Union Bancaire Privee Asset Management first reported a position in WST in Q4 2018 and has held it in 10 quarters since. The position peaked at $4.6M in Q3 2020. 590 funds tracked by Wall St. Rank hold WST as of Q1 2021.

Union Bancaire Privee Asset Management held 10,136 shares of West Pharmaceutical worth $2.86M as of Q1 2021.
Union Bancaire Privee Asset Management sold 3,488 West Pharmaceutical shares in Q1 2021, an estimated $998K.
West Pharmaceutical made up 1.51% of Union Bancaire Privee Asset Management's portfolio in Q1 2021, its #28 holding.
Union Bancaire Privee Asset Management first reported a position in West Pharmaceutical in Q4 2018 and has held it in 10 quarters since.
Union Bancaire Privee Asset Management's West Pharmaceutical position peaked at $4.6M in Q3 2020.
590 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2021.

Based on Union Bancaire Privee Asset Management's 13F filing for Q1 2021, filed 13 Apr 2021.